Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia
Crossref DOI link: https://doi.org/10.1007/s00702-018-1869-1
Published Online: 2018-03-07
Published Print: 2018-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Perez-Lloret, Santiago http://orcid.org/0000-0001-9069-6512
Rascol, Olivier
Text and Data Mining valid from 2018-03-07
Article History
Received: 18 October 2017
Accepted: 27 February 2018
First Online: 7 March 2018